Qualigen Therapeutics is a biotechnology company that develops novel therapeutic products to treat adult and pediatric patients with rare cancers. A leading name in the industry, they have decided to build a therapeutics pipeline within the last few years. In this first episode of a three-part series featuring top executives of Qualigen Therapeutics, Ammon interviews Amy Broidrick, the firm’s President and Chief Strategy Officer. She shares what she brings to the table in the company’s transition from a preclinical stage company to a brand new business venture. She also talks about her deep love for market research, her career’s pivotal and most fulfilling moments, and how she deals with negativity. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
AI Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
A Journey From Investment Banker To The CEO Of A Biotech Developing Cancer Therapy With Bryan Kobel
Biotech Chief People Officer Discusses How To Build Company Culture
Qualigen Therapeutics: How To Develop An Oncology Therapeutics Pipeline From A CMO's Perspective With Tariq Arshad, MD
Mapping The Human Immune System: Using AI To Change Drug Development With Noam Solomon
Free AI-powered recaps of The Best Of BioTech IQ and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.